Developing an effective vaccine against malaria continues to be a challenge, but US researchers think they have a monoclonal antibody candidate that could provide passive immunity against the parasite. Scientists at the National Institutes of Health Clinical ...
from Google Alert - health https://ift.tt/37DlfiM
via IFTTT
0 comments:
Post a Comment